1834 Investment Advisors’s Exact Sciences EXAS Stock Holding History

1834 Investment Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,585	Closed	-$62K	–	280
2022 Q2	$62K	Buy	1,585 +400	+34%	+$21.4K	0.01%	256
2022 Q1	$83K	Sell	1,185 -420	-26%	-$30.7K	0.01%	227
2021 Q4	$125K	Sell	1,605 -430	-21%	-$37.9K	0.01%	217
2021 Q3	$194K	Sell	2,035 -2,190	-52%	-$231K	0.02%	195
2021 Q2	$525K	Buy	4,225 +1,425	+51%	+$170K	0.06%	130
2021 Q1	$369K	Buy	2,800 +1,500	+115%	+$205K	0.05%	147
2020 Q4	$172K	Hold	1,300	–	–	0.02%	202
2020 Q3	$133K	Hold	1,300	–	–	0.02%	215
2020 Q2	$113K	Hold	1,300	–	–	0.02%	213
2020 Q1	$75K	Hold	1,300	–	–	0.01%	231
2019 Q4	$120K	Hold	1,300	–	–	0.02%	228
2019 Q3	$117K	Hold	1,300	–	–	0.02%	231
2019 Q2	$153K	Hold	1,300	–	–	0.02%	210
2019 Q1	$113K	Hold	1,300	–	–	0.02%	222
2018 Q4	$82K	Hold	1,300	–	–	0.01%	232
2018 Q3	$103K	Hold	1,300	–	–	0.02%	236
2018 Q2	$78K	Hold	1,300	–	–	0.01%	245
2018 Q1	$52K	Hold	1,300	–	–	0.01%	270
2017 Q4	$68K	Buy	+1,300	New	+$69.4K	0.01%	268

Other funds holding EXAS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

1834 Investment Advisors's EXAS Position: Q3 2022 in Review

1834 Investment Advisors sold out of Exact Sciences (EXAS) in Q3 2022, closing a stake of 1,585 shares — an estimated $62K sold.

1834 Investment Advisors first reported a position in EXAS in Q4 2017 and held it in 19 quarters. The position peaked at $525K in Q2 2021. 480 funds tracked by Wall St. Rank hold EXAS as of Q3 2022.

1834 Investment Advisors reported no remaining Exact Sciences position as of Q3 2022 after selling out during the quarter.
1834 Investment Advisors sold 1,585 Exact Sciences shares in Q3 2022, an estimated $62K.
1834 Investment Advisors first reported a position in Exact Sciences in Q4 2017 and held it in 19 quarters.
1834 Investment Advisors's Exact Sciences position peaked at $525K in Q2 2021.
480 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2022.

Based on 1834 Investment Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.